These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34459467)

  • 1. Utilizing Advanced Technology to Facilitate Diagnosis of Rare Retinal Disorders: A Case of Bietti Crystalline Dystrophy.
    Choi KY; Wong HHY; Chan HHL
    Optom Vis Sci; 2021 Sep; 98(9):1031-1038. PubMed ID: 34459467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detailed functional and structural phenotype of Bietti crystalline dystrophy associated with mutations in CYP4V2 complicated by choroidal neovascularization.
    Fuerst NM; Serrano L; Han G; Morgan JI; Maguire AM; Leroy BP; Kim BJ; Aleman TS
    Ophthalmic Genet; 2016 Dec; 37(4):445-452. PubMed ID: 27028354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal imaging features and genetic findings in Bietti crystalline dystrophy.
    Wang W; Chen W; Bai X; Chen L
    BMC Ophthalmol; 2020 Aug; 20(1):331. PubMed ID: 32799831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bietti crystalline retinal dystrophy with subfoveal neurosensory detachment and congenital tortuosity of retinal vessels: case report.
    Padhi TR; Kesarwani S; Jalali S
    Doc Ophthalmol; 2011 Jun; 122(3):199-206. PubMed ID: 21611771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailed phenotypic and genotypic characterization of bietti crystalline dystrophy.
    Halford S; Liew G; Mackay DS; Sergouniotis PI; Holt R; Broadgate S; Volpi EV; Ocaka L; Robson AG; Holder GE; Moore AT; Michaelides M; Webster AR
    Ophthalmology; 2014 Jun; 121(6):1174-84. PubMed ID: 24480711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical coherence tomography and optical coherence tomography angiography imaging in Bietti crystalline dystrophy.
    Tiryaki Demir S; Keles Yesiltas S; Kacar H; Akbas EB; Guven D
    Ophthalmic Genet; 2020 Apr; 41(2):194-197. PubMed ID: 32281452
    [No Abstract]   [Full Text] [Related]  

  • 7. TOPICAL DORZOLAMIDE FOR CYSTOID MACULAR EDEMA IN BIETTI CRYSTALLINE RETINAL DYSTROPHY.
    Khojasteh H; Roohipoor R; Riazi-Esfahani H; Ghasempour M
    Retin Cases Brief Rep; 2021 May; 15(3):306-309. PubMed ID: 30028788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presumed Bietti crystalline dystrophy with optic nerve head drusen: a case report.
    Bazvand F; Asadi Khameneh E
    J Med Case Rep; 2022 Nov; 16(1):413. PubMed ID: 36320086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal characterisation of function and structure of Bietti crystalline dystrophy: report on a novel homozygous mutation in
    Lockhart CM; Smith TB; Yang P; Naidu M; Rettie AE; Nath A; Weleber R; Kelly EJ
    Br J Ophthalmol; 2018 Feb; 102(2):187-194. PubMed ID: 28698241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetazolamide for cystoid macular oedema in Bietti crystalline retinal dystrophy.
    Broadhead GK; Chang AA
    Korean J Ophthalmol; 2014 Apr; 28(2):189-91. PubMed ID: 24688265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectral OCT analysis in Bietti crystalline dystrophy.
    Gaucher D; Saleh M; Sauer A; Bourcier T; Speeg-Schatz C
    Eur J Ophthalmol; 2010; 20(3):612-4. PubMed ID: 20099228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mutation of
    Han XY; Zhang LQ; Tang JY; Huang LZ; Tang R; Qu JF
    Int J Ophthalmol; 2022; 15(6):940-946. PubMed ID: 35814885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outer retinal circular structures in patients with Bietti crystalline retinopathy.
    Kojima H; Otani A; Ogino K; Nakagawa S; Makiyama Y; Kurimoto M; Guo C; Yoshimura N
    Br J Ophthalmol; 2012 Mar; 96(3):390-3. PubMed ID: 21803923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bietti crystalline dystrophy: a morpho-functional evaluation.
    Parravano M; Sciamanna M; Giorno P; Boninfante A; Varano M
    Doc Ophthalmol; 2012 Feb; 124(1):73-7. PubMed ID: 22205354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHARACTERIZATION OF MACULAR NEOVASCULARIZATION IN BIETTI CRYSTALLINE DYSTROPHY USING MULTIMODAL IMAGING MODALITIES.
    Li Q; Zhang S; Kang L; Wang D; Jiao X; Hejtmancik JF; Wang L; Peng X
    Retina; 2023 Apr; 43(4):649-658. PubMed ID: 36729825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting visual acuity in Bietti crystalline dystrophy: evaluation of image parameters.
    Huang CY; Kang EY; Yeh LK; Wu AL; Liu PK; Huang IW; Ryu J; Liu L; Wu WC; Lai CC; Chen KJ; Wang NK
    BMC Ophthalmol; 2021 Feb; 21(1):68. PubMed ID: 33541298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outer retinal tubulation in inherited retinal degenerative disease.
    Iriyama A; Aihara Y; Yanagi Y
    Retina; 2013; 33(7):1462-5. PubMed ID: 23538577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and clinical findings in 3 female siblings with crystalline retinopathy.
    Chen H; Zhang M; Huang S; Wu D
    Doc Ophthalmol; 2008 May; 116(3):237-43. PubMed ID: 17962988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UTILIZATION OF FUNDUS AUTOFLUORESCENCE, SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY, AND ENHANCED DEPTH IMAGING IN THE CHARACTERIZATION OF BIETTI CRYSTALLINE DYSTROPHY IN DIFFERENT STAGES.
    Li Q; Li Y; Zhang X; Xu Z; Zhu X; Ma K; She H; Peng X
    Retina; 2015 Oct; 35(10):2074-84. PubMed ID: 25978730
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.